EN
A
ABCL
Abcellera Biologics Inc.
11.82
+0.45+3.96%After Hours: 11.74 -0.08 -0.68%19:58 10/23 EDT
OPEN/PREV CLOSE12.67/12.83
TODAY RANGE12.65-13.65
VOL11.34K
MARKET CAP4.42B
52 WEEK RANGE2.745-15.02
AVG VOL (3M)6.45M
% TURNOVER0.89%
TURNOVER0
P/E (TTM)-25.0413
% RANGE7.77%
EPS(TTM)-0.5447
P/E(FORWARD)-20.4241
P/B4.665
BVPS2.924
DIVIDEND--
P/S54.58
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.46B
SHARES OUTSTANDING323.91M
NEXT EARNINGS11/04-11/09
FREE FLOAT253.50M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
Did Positive Phase 2 Results Just Shift AbCellera Biologics' (ABCL) Investment Narrative?
Simply Wall St·5d ago
Is AbCellera Biologics (ABCL) Undervalued After Encouraging Phase 2 Data For ABCL635?
Simply Wall St·10/22 11:34
AbCellera Biologics Is Up 124% Even As Sales Fell
Seeking Alpha·10/22 08:45
AbCellera Has Promising Menopause Data, But Much Of The Opportunity Is Priced In
Simply Wall St·10/13 06:22
After AbCellera Biologics' 125% Climb, The Story Has Changed
TipRanks·10/11 23:35
AbCellera initiated with a Buy at UBS
Simply Wall St·10/11 01:39
Is AbCellera Biologics (ABCL) Undervalued After New ABCL635 Data Presentation Plans?
Simply Wall St·10/10 00:29
Clinical Data Update Might Change The Case For Investing In AbCellera Biologics Stock
TipRanks·10/08 20:11
AbCellera to present Phase 1/2 data for ABCL635 at TMS 2026 Annual Meeting
NASDAQ·09/30 10:14
Biotech Stocks At 52-Week Highs - IOVA +31%, XERS, GRAL, ABCL, SGHT
TipRanks·09/29 19:05
AbCellera Biologics call volume above normal and directionally bullish
Dow Jones·09/29 13:25
AbCellera Biologics Initiated at Overweight by JP Morgan
Dow Jones·09/29 13:25
AbCellera Biologics Price Target Announced at $17.00/Share by JP Morgan
TipRanks·09/29 10:05
AbCellera initiated with an Overweight at JPMorgan
Same Industry
Name/Symbol
Change%
Price